The Thoroughbred Owners and Breeders Association supports the recent proposal by the leaders of the Association of Racing Commissioners International to develop a plan to eliminate the use of medications in Thoroughbred racehorses in competition.

TOBA president Dan Metzger said, “Our current medication policy impairs our ability to compete in the domestic gambling and entertainment market, as well as the international bloodstock market, due to the widespread perception that our horses are over-medicated.  We can no longer ignore that sentiment.

“TOBA looks forward to working with other industry organizations to develop and implement a plan that will phase out the use of race-day medications so that our medication policies are consistent with the rest of the racing world.

“The industry has demonstrated that it can work together to strengthen the integrity of the sport when it decided to ban the use of androgenic anabolic steroids.  Racing did not come to an end when that change to medication policy was made and we believe this step is another in the process of increasing the integrity of our sport for all participants.”